Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum
Por:
Ali, M, Western, D, Liu, MH, Beric, A, Budde, J, Do, A, Heo, G, Wang, LH, Gentsch, J, Schindler, SE, Morris, JC, Holtzman, DM, Ruiz, A, Alvarez, I, Aguilar, M, Pastor, P, Rutledge, J, Oh, H, Wilson, EN, Le Guen, Y, Khalid, RR, Robins, C, Pulford, DJ, Tarawneh, R, Ibanez, L, Wyss-Coray, T, Sung, YJ, Cruchaga, C and Timsina, J
Publicada:
7 may 2025
Ahead of Print:
1 may 2025
Resumen:
Changes in b-amyloid (Ab) and hyperphosphorylated tau (T) in brain and cerebrospinal fluid (CSF) precede Alzheimer's disease (AD) symptoms, making the CSF proteome a potential avenue to understand disease pathophysiology and facilitate reliable diagnostics and therapies. Using the AT framework and a three-stage study design (discovery, replication, and meta-analysis), we identified 2,173 analytes (2,029 unique proteins) dysregulated in AD. Of these, 865 (43%) were previously reported, and 1,164 (57%) are novel. The identified proteins cluster in four different pseudo-trajectories groups spanning the AD continuum and were enriched in pathways including neuronal death, apoptosis, and tau phosphorylation (early stages), microglia dysregulation and endolysosomal dysfunction (mid stages), brain plasticity and longevity (mid stages), and microglianeuron crosstalk (late stages). Using machine learning, we created and validated highly accurate and replicable (area under the curve [AUC] > 0.90) models that predict AD biomarker positivity and clinical status. These models can also identify people that will convert to AD.
Filiaciones:
Ali, M:
Washington Univ St Louis, Dept Psychiat, St Louis, MO 63130 USA
Western, D:
Washington Univ St Louis, Dept Psychiat, St Louis, MO 63130 USA
Liu, MH:
Washington Univ St Louis, Dept Psychiat, St Louis, MO 63130 USA
Beric, A:
Washington Univ St Louis, Dept Psychiat, St Louis, MO 63130 USA
Budde, J:
Washington Univ St Louis, Dept Psychiat, St Louis, MO 63130 USA
Do, A:
Washington Univ St Louis, Dept Psychiat, St Louis, MO 63130 USA
Heo, G:
Washington Univ St Louis, Dept Psychiat, St Louis, MO 63130 USA
Wang, LH:
Washington Univ St Louis, Dept Psychiat, St Louis, MO 63130 USA
Gentsch, J:
Washington Univ St Louis, Dept Psychiat, St Louis, MO 63130 USA
Schindler, SE:
Washington Univ St Louis, Dept Neurol, St Louis, MO 63130 USA
Morris, JC:
Washington Univ St Louis, Dept Neurol, St Louis, MO 63130 USA
Holtzman, DM:
Washington Univ St Louis, Dept Neurol, St Louis, MO 63130 USA
Ruiz, A:
Ace Alzheimer Ctr Barcelona, Barcelona, Spain
:
Fundacio Docencia & Recerca Mutua Terrassa, Barcelona, Spain
Aguilar, M:
Fundacio Docencia & Recerca Mutua Terrassa, Barcelona, Spain
:
Fundacio Docencia & Recerca Mutua Terrassa, Barcelona, Spain
Rutledge, J:
Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA
Oh, H:
Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA
Wilson, EN:
Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA
Le Guen, Y:
Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA
Khalid, RR:
Quaid I Azam Univ, NCB, Islamabad, Pakistan
Robins, C:
GSK Pharm R&D, Genom Sci, 1250 S Collegeville Rd, Collegeville, PA 19426 USA
Pulford, DJ:
GSK Pharm R&D, Genom Sci, 1250 S Collegeville Rd, Collegeville, PA 19426 USA
Tarawneh, R:
Univ New Mexico, Albuquerque, NM 87131 USA
Ibanez, L:
Washington Univ St Louis, Dept Psychiat, St Louis, MO 63130 USA
Wyss-Coray, T:
Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA
Sung, YJ:
Washington Univ St Louis, Dept Psychiat, St Louis, MO 63130 USA
Cruchaga, C:
Washington Univ St Louis, Dept Psychiat, St Louis, MO 63130 USA
Washington Univ, Knight Alzheimers Dis Res Ctr, St Louis, MO 63110 USA
Timsina, J:
Washington Univ St Louis, Dept Psychiat, St Louis, MO 63130 USA
Green Submitted, hybrid
|